The Vaccine Taskforce in the United Kingdom of Great Britain and Northern Ireland was set up in April 2020 by the Second Johnson ministry, in collaboration with Chief Scientific Advisor Patrick Vallance and Chief Medical Officer Professor Chris Whitty, in order to facilitate the path towards the introduction of a COVID-19 vaccine in the UK and its global distribution. The taskforce coordinated the research efforts of government with industry, academics and funding agencies in order to expedite vaccine development and deployment. The minister responsible for the body was the Secretary of State for Health and Social Care, although the body was a joint unit of the Department of Health and Social Care and the Department for Business, Energy and Industrial Strategy. Oversight was by the Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment, and in November 2020 the first person to take this role was Nadhim Zahawi MP. The Vaccine Taskforce closed in autumn 2022. Its role in vaccine supply was merged into the UK Health Security Agency, and its work in bringing vaccine manufacture in-country transferred to the Office for Life Sciences.
History The body was set up in April 2020 by the Government's Chief Scientific Advisor, Sir Patrick Vallance. On 16 May 2020, venture capitalist Kate Bingham was named to chair the body. On 1 July, Bingham told the Science and Technology Select Committee that Sarah Gilbert and "Oxford University (are) leading the world in developing a vaccine against COVID-19 and offers the best chance of having something protective against the virus as we go into winter." On 12 September, it came to light that Sir John Bell was a member of the body. On 14 October, the chair managed public expectation by stating that a vaccine for COVID-19 was expected to be no more efficacious than the flu vaccine, which immunises against the influenza virus with around 50 per cent success. Bingham added: "We shouldn't assume it's going to be better than a flu vaccine, because that's an equivalent – it's a mutating … respiratory virus that gets in through the nose and eyes and respiratory tract". Speaking to BBC Scotland's The Seven on 17 October, Bingham said that the government would have to arrive at an agreement with the Joint Committee on Vaccination and Immunisation (JCVI) as to how any COVID-19 vaccine should be distributed; the staff of care homes and the elderly are likely to be prioritised. She stated that initially there would be a limited supply any COVID-19 vaccine. On 18 October 2020, SAGE committee member, Sir Jeremy Farrar, commented on Sophy Ridge On Sunday that the Vaccine Taskforce "has done an absolutely extraordinary job" and the country is in an "extraordinarily strong position" with regard to the line-up of possible vaccines. A government press release of 20 October shed further light on the initial formation of the taskforce, stating that it was created under the auspices of the Department for Business, Energy and Industrial Strategy (BEIS) in May 2020. Nadhim Zahawi was appointed to the new role of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment on 28 November 2020, with responsibility for the taskforce. On 1 March 2021, ministerial responsibility transferred from BEIS to the Secretary of State for Health and Social Care, and the taskforce became a joint unit of BEIS and the Department of Health and Social Care.
Personnel On 14 June 2021, the microbiologist Sir Richard Sykes was appointed chair of the Vaccine Taskforce. As of June 2022, the director-general of the taskforce is Madelaine McTernan.
Steering group In June 2021, the Department for Business, Energy and Industrial Strategy confirmed in response to a Freedom of Information Act request that the taskforce's formal steering group had been disbanded, with the taskforce now being managed by a senior leadership team of civil servants and experts, with Sir Richard Sykes as its external chair.
Former membership Until November 2020, the membership of the taskforce was unknown. A Freedom of Information Act request to obtain the membership was responded to with three pages of redacted names. As of that month, the steering group was made up of:
Kate Bingham, chair Clive Dix, deputy chair Nick Elliott MBE, Director-General, Department for Business, Energy and Industrial Strategy (BEIS) Ruth Todd, Director, BEIS Madelaine McTernan, Director, UK Government Investments Tim Colley, Director, BEIS Dan Osgood, Director, BEIS Divya Chadha Manek, National Institute for Health Research Ian McCubbin, Manufacturing Advisor – former Senior Vice President for Global Manufacturing and Supply at GlaxoSmithKline Steve Bates, Chief Executive Officer, BioIndustry Association Professor Jonathan Van-Tam, Clinical and Public Health Adviser to the VTF, Deputy Chief Medical Officer, Department of Health and Social Care Representatives of other government departments and public sector organisations attended VTF Steering Group meetings as required
… excerpt ends here. Continue reading the full article.


